This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cost-Effectiveness of Revascularization Strategies: The ASCERT Study
In 2012 the American College of Cardiology Foundation and the Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies (ASCERT) compared the 5 year effectiveness of CABG versus PCI. The registry data is now linked with Centeres for Meidcare and Medicaid Services Claims data in order to study the long-term cost-effectiveness of the two strategies. The authors found that the life-time incremental cost-effectiveness ratio of CABG versus PCI was approximately $30,000/QALY gained, a value that is generally considered economically attractive.